Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial
Pharmacology, Toxicology and Pharmaceutical Science
3
2%
Physics and Astronomy
3
2%
Other
10
7%
Unknown
53
35%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 29. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 May 2022.
All research outputs
#1,631,859
of 32,375,021 outputs
Outputs from JAMA Oncology
#2,027
of 3,850 outputs
Outputs of similar age
#16,436
of 294,950 outputs
Outputs of similar age from JAMA Oncology
#49
of 94 outputs
Altmetric has tracked 32,375,021 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,850 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 84.1. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 294,950 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 94 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
